In the bioscience field we are expecting government spending is increased this fiscal year, especially in Japan. In addition to cutting-edge products into which we are currently focusing our investment of resources, we will aim to expand sales by increasing our market share in biological microscopes for research and clinical use targeting general users. In the way of regions, we aim to expand sales in Japan and the rest of Asia.
In the industrial instruments field we will invest human resources and development costs into non-contact 3D measuring systems, which is an area that is expected to grow. We are going to focus on the markets in emerging countries in Asia, such as Indonesia, Vietnam and Thailand, and on automotive and aircraft industries.